Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Positron Emitting Activity [MoA]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
GALLIUM GA-OZETOTIDE 204 4 2.0% 35 5 70.0 yrs 0.0%
PIFLUFOLASTAT F-18 191 0 N/A 3 0 69.4 yrs 3.4%
FLUCICLOVINE F-18 102 2 2.0% 2 0 68.3 yrs 4.3%
FLORBETAPIR F-18 99 1 1.0% 9 0 73.1 yrs 57.1%
COPPER OXODOTREOTIDE CU-64 47 0 N/A 1 0 63.2 yrs 82.1%
FLOTUFOLASTAT F-18 23 0 N/A 0 0 69.4 yrs 0.0%
FLORBETABEN F-18 16 0 N/A 2 0 73.0 yrs 62.5%
FLUOROESTRADIOL F-18 11 0 N/A 0 0 56.6 yrs 100.0%

Head-to-Head Comparisons

GALLIUM GA-OZETOTIDE vs PIFLUFOLASTAT F-18 GALLIUM GA-OZETOTIDE vs FLUCICLOVINE F-18 GALLIUM GA-OZETOTIDE vs FLORBETAPIR F-18 GALLIUM GA-OZETOTIDE vs COPPER OXODOTREOTIDE CU-64 PIFLUFOLASTAT F-18 vs FLUCICLOVINE F-18 PIFLUFOLASTAT F-18 vs FLORBETAPIR F-18 PIFLUFOLASTAT F-18 vs COPPER OXODOTREOTIDE CU-64 FLUCICLOVINE F-18 vs FLORBETAPIR F-18 FLUCICLOVINE F-18 vs COPPER OXODOTREOTIDE CU-64 FLORBETAPIR F-18 vs COPPER OXODOTREOTIDE CU-64
← Back to Positron Emitting Activity [MoA] Class side effects →